Trials / Completed
CompletedNCT00228514
Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study
Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) PET Sub Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
At one site, patients participating in the Corona main study are asked to participate in the PET-substudy. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed to study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | |
| PROCEDURE | Positron emission tomography |
Timeline
- Start date
- 2004-02-01
- Completion
- 2007-07-01
- First posted
- 2005-09-29
- Last updated
- 2010-11-15
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00228514. Inclusion in this directory is not an endorsement.